Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Connelly

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Diabetes Research and Clinical Practice|May 7, 2015
Associations of circulating 25(OH)D with cardiometabolic disorders underlying type 2 diabetes mellitus in an Aboriginal Canadian communitySudaba Mansuri, Alaa Badawi, Sheena Kayaniyil, et al.
The American Journal of Cardiology|February 15, 1994
Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemiaJ Davignon, G Roederer, M Montigny, et al.
Diabetes Care|March 15, 2008
Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes ProjectSylvia H Ley, Stewart B Harris, Philip W Connelly, et al.
Metabolism: Clinical and Experimental|May 1, 1993
The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiberD J Jenkins, R A Hegele, A L Jenkins, et al.
Clinical Chemistry|January 30, 2010
Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian populationSylvia H Ley, Stewart B Harris, Philip W Connelly, et al.
BMJ Open|April 15, 2018
Patient preferences for nutritional supplementation to improve fracture healing: a discrete choice experimentElizabeth Nichols, Nathan N O'Hara, Yasmin Degani, et al.
Diabetes, Obesity & Metabolism|April 19, 2012
Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes riskS H Ley, S B Harris, P W Connelly, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|April 29, 2021
The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic reviewZhila Semnani-Azad, Sonia Blanco Mejia, Philip W Connelly, et al.
The Journal of Clinical Investigation|May 26, 2001
A major role for VCAM-1, but not ICAM-1, in early atherosclerosisM I Cybulsky, K Iiyama, H Li, et al.
Atherosclerosis|March 21, 2001
Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populationsR A Hegele, J Wang, S B Harris, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Diabetes Research and Clinical Practice|May 7, 2015
Associations of circulating 25(OH)D with cardiometabolic disorders underlying type 2 diabetes mellitus in an Aboriginal Canadian communitySudaba Mansuri, Alaa Badawi, Sheena Kayaniyil, et al.
The American Journal of Cardiology|February 15, 1994
Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemiaJ Davignon, G Roederer, M Montigny, et al.
Diabetes Care|March 15, 2008
Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes ProjectSylvia H Ley, Stewart B Harris, Philip W Connelly, et al.
Metabolism: Clinical and Experimental|May 1, 1993
The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiberD J Jenkins, R A Hegele, A L Jenkins, et al.
Clinical Chemistry|January 30, 2010
Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian populationSylvia H Ley, Stewart B Harris, Philip W Connelly, et al.
BMJ Open|April 15, 2018
Patient preferences for nutritional supplementation to improve fracture healing: a discrete choice experimentElizabeth Nichols, Nathan N O'Hara, Yasmin Degani, et al.
Diabetes, Obesity & Metabolism|April 19, 2012
Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes riskS H Ley, S B Harris, P W Connelly, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|April 29, 2021
The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic reviewZhila Semnani-Azad, Sonia Blanco Mejia, Philip W Connelly, et al.
The Journal of Clinical Investigation|May 26, 2001
A major role for VCAM-1, but not ICAM-1, in early atherosclerosisM I Cybulsky, K Iiyama, H Li, et al.
Atherosclerosis|March 21, 2001
Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populationsR A Hegele, J Wang, S B Harris, et al.
Pageof 32